Press releases

Sep 6

Sachi Bio’s New Treatment Featured by Multiple Media Outlets: A “game-changing tool” in fight against Alzheimer’s, Dementia, and Aging

KEYWORDS: Alzheimer’s, aging, dementia, treatment, Nanoligomer Read more at: Denver Post Colorado State University Press release DENVER -...

Sep 2

Age-reversing effects of Sachi's Drug Molecule published in the Journal of Neuroinflammation

As the brain gets older or in conditions like Alzheimer’s, inflammation becomes a major problem that damages brain cells, leading to...

Apr 15

Sachi Bio wins NASA Phase IIE and III contracts to Develop Neuroprotective Countermeasures for Long-term Space travel

Sachi Bio won Phase IIE and Phase III contracts from the NASA Human Research Program to continue advancement of the Neurotherapeutic...

Mar 31

Investigational New Drug (IND)-enabling Studies for Sachi Bio's lead molecule

Sachi Bio's lead program NI112 shows excellent Safety-Toxicity, brain-delivery, and biodistribution profile in Investigational New Drug...

Jan 31

Sachi Bio lead programs to support NASA Missions & counter debilitating diseases on Earth

"Sachi Bio has successfully advanced it's lead program towards translation for a range of neurodegenerative diseases, as well as a...

Aug 31, 2023

Sachi Bio presents at ISSR&D Conference as it aims to become the first company in the world to test RNA Therapeutics in Space

Sachi Bio presented data on human brain organoids and their treatment with Nanoligomers, to the space community in the ISSR&D conference...

Ph: 720-361-2159

3000 Airport Drive, Unit 201,

Erie, CO 80516

Subscribe to Our Newsletter